Liquid biopsy in Central Nervous System metastases: a RANO review and proposals for clinical applications.

Liquid biopsy in Central Nervous System metastases: a RANO review and proposals for clinical applications.

Neuro Oncol. 2019 Jan 22;:

Authors: Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junk L, Glantz M, Groves MD, Lee EQ, Lin N, Raizer J, Rudà R, Weller M, van den Bent MJ, Vogelbaum MA, Chang S, Wen PY, Soffietti R

Abstract
Liquid biopsies collect and analyze tumor components in body fluids, and there is an increasing interest in the investigation of liquid biopsies as a surrogate for tumor tissue in the management of both primary and secondary brain tumors. Herein we critically review available literature on spinal fluid and plasma circulating tumor cells (CTCs) and cell-free tumor (ctDNA) for diagnosis and monitoring of leptomeningeal and parenchymal brain metastases. We discuss technical issues and propose several potential applications of liquid biopsies in different clinical settings, i.e. for initial diagnosis, for assessment during treatment and for guidance of treatment decisions. Last, ongoing clinical studies on CNS metastases, that include liquid biopsies, are summarized and recommendations for future clinical studies are provided.

PMID: 30668804 [PubMed - as supplied by publisher]

from A via a.sfakia on Inoreader http://bit.ly/2S5n8QS